Search

everythinglearnresearchcommunity

for

Search:↓

A mutation in the SREBF1 gene causes both hereditary mucoepithelial dysplasia and IFAP syndrome, which are related conditions.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Fluocinolone acetonide slows down hair follicle stem cells but speeds up skin cell growth in mice.

Hair follicle cells produce VEGF, which can promote blood vessel cell growth and movement.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

The buffy coat method yields higher TGF-β1 levels in PRP, especially in males.

Fgf20 helps form hair follicle structures by stopping cell division and increasing cell movement.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

Phenoxyethanol in hair growth products may be linked to frontal fibrosing alopecia.

TCF/Lef1 is essential for skin barrier function by regulating lipid metabolism.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

Understanding fibroblast issues in diabetic foot ulcers is key to creating better treatments.